Pfizer Limited (NSE:PFIZER)
India · Delayed Price · Currency is INR 5,352.00
-79.00 (-1.45%)
Jul 16, 2025, 3:29 PM IST
Pfizer Revenue
In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 22.81B INR with 4.02% growth. Pfizer had revenue of 5.92B in the quarter ending March 31, 2025, with 8.28% growth.
Revenue
22.81B
Revenue Growth
+4.02%
P/S Ratio
10.89
Revenue / Employee
14.28M
Employees
1,598
Market Cap
248.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |